Live News EQUITY L impact Jul 21, 2026, 02:04 PM UTC

Gilead, Merck report 'high' rates of virologic suppression in ISLEND trials

Gilead, Merck report 'high' rates of virologic suppression in ISLEND trials

GILD.US.STK.MRK.US.STK.G

SquawkNews Newsroom

Gilead, Merck report 'high' rates of virologic suppression in ISLEND trials